Gene · 868
Papers1,946
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 1,946
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Targeting intracellular immune regulatory molecules for cancer immunotherapy in solid tumors. | Crit Rev Oncol Hematol | 2026 | 42732787 | PubTator, text mining | PubMed |
| Discovery of Cbl-b Targeting Cyclic Peptide Ligands by Phage Display. | Org Lett | 2026 | 42726242 | PubTator, text mining | PubMed |
| Pushing the boundaries of virtual screening scale of combinatorial spaces with the V-SYNTHES approach. | NPJ Drug Discov | 2026 | 42686876 | PubTator, text mining | PubMed |
| β-Hydroxy-β-methylbutyrate (HMB) Counteracts Atrophy and Restores Circadian Rhythms in Myotubes. | Int J Mol Sci | 2026 | 42511533 | PubTator, text mining | PubMed |
| Correction: miR-1323 promotes cell migration in lung adenocarcinoma by targeting Cbl-b and is an early prognostic biomarker. | Front Oncol | 2026 | 42491279 | PubTator, text mining | PubMed |
| CRISPR/Cas9-Mediated Gene Knockout Reveals a Nonredundant Role for p16INK4A in Controlling TCR-Dependent and Independent CD8 T Cell Expansion. | Eur J Immunol | 2026 | 42345443 | PubTator, text mining | PubMed |
| Tumor Treating Fields modulate apoptotic and immune programs in T-cell acute lymphoblastic leukemia cell lines. | Exp Ther Med | 2026 | 42305707 | PubTator, text mining | PubMed |
| Identification of ubiquitination-related biomarkers in osteoarthritis: Combining transcriptome and Mendelian randomization analysis. | SLAS Technol | 2026 | 42285256 | PubTator, text mining | PubMed |
| N6-methyladenosine modification of CBLB affects LPS-induced endoplasmic reticulum stress in alveolar epithelial cells. | Cent Eur J Immunol | 2026 | 42245124 | PubTator, text mining | PubMed |
| Ablation of Cbl-b in ROBO1 CAR-NK92 Cells Enhances Their Antitumor Efficacy. | Hum Gene Ther | 2026 | 42204417 | PubTator, text mining | PubMed |
| CBLB inhibits papillary thyroid cancer malignancy via negatively regulating MYCBP/c-Myc axis. | Cell Signal | 2026 | 42191055 | PubTator, text mining | PubMed |
| Small-molecule CBLB inhibitor abolishes EGFR ubiquitination, reduces receptor endocytosis and diminishes cell motility signaling. | bioRxiv | 2026 | 42124681 | PubTator, text mining | PubMed |
| Discovery, biological evaluation, and molecular modeling of novel alkylamine-based Cbl-b inhibitors. | Bioorg Chem | 2026 | 42068811 | PubTator, text mining | PubMed |
| Small-molecule CBLB inhibitor abolishes EGFR ubiquitination, reduces receptor endocytosis, and diminishes cell motility signaling. | Proc Natl Acad Sci U S A | 2026 | 41894323 | PubTator, text mining | PubMed |
| Current Status of Newborn Screening in Southeastern and Central Europe. | Int J Neonatal Screen | 2026 | 41892022 | PubTator, text mining | PubMed |
| ORMDL3: from an asthma susceptibility gene to multi-disease associations. | Front Genet | 2026 | 41884618 | PubTator, text mining | PubMed |
| Molecular mechanisms of NLRP3 inflammasome activation. | Exp Mol Med | 2026 | 41876821 | PubTator, text mining | PubMed |
| Exosomal non-coding RNAs in autoimmune diseases: molecular mechanisms and potential applications. | Front Immunol | 2026 | 41798919 | PubTator, text mining | PubMed |
| Mechanism of CircBbs9 in Lung Epithelial Cell Ferroptosis in Lipopolysaccharide-Induced Acute Lung Injury. | FASEB J | 2026 | 41779432 | PubTator, text mining | PubMed |
| Reprogramming the immunosuppressive breast cancer microenvironment: integrating cellular, metabolic, and stromal targets for rational immunotherapy. | Front Immunol | 2026 | 41766877 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/868/papers